The Strategy of Antivirus Treatment in Reproductive Women Infected with Hepatitis B Virus

[1]  M. Manns,et al.  Treatment of chronic hepatitis B. , 2010, Minerva gastroenterologica e dietologica.

[2]  Lin Shen,et al.  The HBV drug entecavir - effects on HIV-1 replication and resistance. , 2007, The New England journal of medicine.

[3]  J. Hoofnagle,et al.  Management of hepatitis B: Summary of a clinical research workshop , 2007, Hepatology.

[4]  H. Cai,et al.  [The safety and effect of lamivudine in treating pregnant women infected with hepatitis B virus]. , 2006, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[5]  De-zhong Xu,et al.  Preliminary study on the efficacy and safety of lamivudine and interferon α therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy , 2005, Journal of medical virology.

[6]  M. Foss,et al.  Effect of maternal use of antiretroviral agents on serum insulin levels of the newborn infant. , 2005, Diabetes care.

[7]  M. Senzolo,et al.  Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft , 2004, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  K. Nagashima,et al.  Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir , 2004, AIDS.

[9]  K. Pan,et al.  Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. , 2004, World journal of gastroenterology.

[10]  H. Tilson,et al.  Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy. , 2003, American journal of obstetrics and gynecology.

[11]  L. Schnaas,et al.  Effects of prenatal exposure to Zidovudine and Lamivudine on brainstem auditory evoked potentials in infants from HIV-infected women. , 2004, Proceedings of the Western Pharmacology Society.

[12]  L. Zou,et al.  Interruption of HBV intrauterine transmission: a clinical study. , 2003, World journal of gastroenterology.

[13]  H. Janssen,et al.  Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection , 2003, Journal of viral hepatitis.

[14]  F. Denis,et al.  Virus des hepatites : transmission mere-enfant , 2002 .

[15]  S. Alain,et al.  [Hepatitis viruses: mother to child transmission]. , 2002, Pathologie-biologie.

[16]  E. Alleva,et al.  Prenatal AZT or 3TC and mouse development of locomotor activity and hot-plate responding upon administration of the GABAA receptor agonist muscimol , 2001, Psychopharmacology.

[17]  L. Mandelbrot,et al.  Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women. , 2001, American journal of obstetrics and gynecology.

[18]  E. Alleva,et al.  Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice. , 2001, Teratology.

[19]  P. Rustin,et al.  Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues , 1999, The Lancet.

[20]  E. Alleva,et al.  Neurobehavioral effects of prenatal lamivudine (3TC) exposure in preweaning mice. , 1999, Neurotoxicology and teratology.

[21]  G. E. Pakes,et al.  Clinical Pharmacokinetics of Lamivudine , 1999, Clinical pharmacokinetics.

[22]  P. Harrigan,et al.  Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. , 1998, The Journal of infectious diseases.